Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
S-3Simplified registration formDec 20, 2002View HTMLDownload DOCDownload PDFDownload XLS
POS AMPost-effective amendment to an S-Type filingOct 3, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-A12GRegistration of certain classes of securities 12(g) of the Securities Exchange ActSep 13, 2002View HTMLDownload DOCDownload PDFDownload XLS
424B3Form of prospectus reflecting facts events constituting substantive change from last formSep 13, 2002View HTMLDownload DOCDownload PDFDownload XLS
S-3/APre-effective amendment to an S-3 filingJul 26, 2002View HTMLDownload DOCDownload PDFDownload XLS
S-3/APre-effective amendment to an S-3 filingJul 5, 2002View HTMLDownload DOCDownload PDFDownload XLS
S-3Simplified registration formApr 25, 2002View HTMLDownload DOCDownload PDFDownload XLS
S-8Securities offered to employees pursuant to employee benefit plansApr 2, 2002View HTMLDownload DOCDownload PDFDownload XLS

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information